story

Lucero

Lucero Bio enables scalable 3D cell culture for preclinical drug development, combining microbiology, artificial intelligence, and microfluidics as a bioconvergence company to deliver more accurate, efficient, and advanced biomedical research solutions.

Biotech, Sweden


About Lucero

Founded in 2020, Lucero is a bioconvergence company integrating microbiology, AI and microfluidics to advance modern research. Its technology addresses major challenges in 3D cell-culture handling, miniaturization, and assay preparation, enabling precise, scalable, and automated experimentation that accelerates next-generation biomedical innovation.

Legal Name

: Lucero

Headquarters

: Gothenburg, Sweden

Business Model

: B2B, B2C

Founding Date

: 2020

No. of Employees

: 2-10

Founding Members

: 1. Christopher Jacklin Co-Founder & CEO


Recently Added Startups